Bansback NJ, Ara R, Barkham N ym. Estimating the cost and health status consequences
of treatment with TNF antagonists in patients with psoriatic arthritis. Rheumatology
(Oxford) 2006;45:1029-38 «PMID: 16782734»PubMed
Bojke L, Claxton K, Bravo-Vergel Y ym. Eliciting distributions to populate decision
analytic models. Value Health 2010;13:557-64 «PMID: 20345548»PubMed
Bojke L, Epstein D, Craig D ym. Modelling the cost-effectiveness of biologic treatments
for psoriatic arthritis. Rheumatology (Oxford) 2011;50 Suppl 4:iv39-iv47 «PMID: 21859705»PubMed
Bravo Vergel Y, Hawkins NS, Claxton K ym. The cost-effectiveness of etanercept and
infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford)
2007;46:1729-35 «PMID: 17956918»PubMed
Cawson MR, Mitchell SA, Knight C ym. Systematic review, network meta-analysis and
economic evaluation of biological therapy for the management of active psoriatic arthritis.
BMC Musculoskelet Disord 2014;15:26 «PMID: 24444034»PubMed
Cummins E, Asseburg C, Punekar YS ym. Cost-effectiveness of infliximab for the treatment
of active and progressive psoriatic arthritis. Value Health 2011;14:15-23 «PMID: 21211482»PubMed
Cummins E, Asseburg C, Prasad M ym. Cost effectiveness of golimumab for the treatment
of active psoriatic arthritis. Eur J Health Econ 2012;13:801-9 «PMID: 21720868»PubMed
Epstein D, Sutton A. Modelling correlated clinical outcomes in health technology appraisal.
Value Health 2011;14:793-9 «PMID: 21914498»PubMed
O'Connor J, Rice S, Smith A ym. The Clinical and Cost Effectiveness of Ustekinumab
for the Treatment of Psoriatic Arthritis: A Critique of the Evidence. Pharmacoeconomics
2016;34:337-48 «PMID: 26818809»PubMed
Rodgers M, Epstein D, Bojke L ym. Etanercept, infliximab and adalimumab for the treatment
of psoriatic arthritis: a systematic review and economic evaluation. Health Technol
Assess 2011;15:i-xxi, 1-329 «PMID: 21333232»PubMed
Woolacott N, Bravo Vergel Y, Hawkins N ym. Etanercept and infliximab for the treatment
of psoriatic arthritis: a systematic review and economic evaluation. Health Technol
Assess 2006;10:iii-iv, xiii-xvi, 1-239 «PMID: 16948890»PubMed
Yang H, Epstein D, Bojke L ym. Golimumab for the treatment of psoriatic arthritis.
Health Technol Assess 2011;15 Suppl 1:87-95 «PMID: 21609657»PubMed
Yang H, Craig D, Epstein D ym. Golimumab for the treatment of psoriatic arthritis:
a NICE single technology appraisal. Pharmacoeconomics 2012;30:257-70 «PMID: 22283690»PubMed
